CannaPharmaRx, Inc. (CPMD) stock
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
CannaPharmaRx's free cash flow for the twelve months ending Dec 31, 2025 was -$794.62K. For fiscal 2025 it was -$794.62K. The highest annual figure on record is -$22.38K in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$794.62K | – |
| FY2024 | Dec 31, 2024 | -$1.70M | – |
| FY2023 | Dec 31, 2023 | -$2.36M | – |
| FY2022 | Dec 31, 2022 | -$1.56M | – |
| FY2019 | Dec 31, 2019 | -$3.80M | – |
| FY2018 | Dec 31, 2018 | -$941.14K | – |
| FY2016 | Dec 31, 2016 | -$22.38K | – |
| FY2015 | Dec 31, 2015 | -$2.55M | – |
| FY2014 | Dec 31, 2014 | -$1.64M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$167.24K | – |
| Q4 FY2025 | Dec 31, 2025 | $1.06M | – |
| Q3 FY2025 | Sep 30, 2025 | -$802.70K | – |
| Q4 FY2024 | Dec 31, 2024 | -$179.89K | – |
| Q3 FY2024 | Sep 30, 2024 | -$540.90K | -551.9% |
| Q2 FY2024 | Jun 30, 2024 | -$427.62K | – |
| Q1 FY2024 | Mar 31, 2024 | -$548.83K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.31M | – |
| Q3 FY2023 | Sep 30, 2023 | $119.70K | – |
| Q2 FY2023 | Jun 30, 2023 | -$555.98K | – |
| Q1 FY2023 | Mar 31, 2023 | -$612.63K | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.10M | – |
| Q4 FY2019 | Dec 31, 2019 | -$975.39K | – |
| Q4 FY2018 | Dec 31, 2018 | -$734.89K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1 | – |
See a number that looks wrong?